These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Addictiveness of central stimulants. Dackis CA; Gold MS Adv Alcohol Subst Abuse; 1990; 9(1-2):9-26. PubMed ID: 1974121 [TBL] [Abstract][Full Text] [Related]
5. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes. Regier PS; Kampman KM; Childress AR Handb Exp Pharmacol; 2020; 258():299-322. PubMed ID: 32193666 [TBL] [Abstract][Full Text] [Related]
6. Nondependent stimulant users of cocaine and prescription amphetamines show verbal learning and memory deficits. Reske M; Eidt CA; Delis DC; Paulus MP Biol Psychiatry; 2010 Oct; 68(8):762-9. PubMed ID: 20605137 [TBL] [Abstract][Full Text] [Related]
7. Adverse effects of stimulant drugs in a community sample of drug users. Williamson S; Gossop M; Powis B; Griffiths P; Fountain J; Strang J Drug Alcohol Depend; 1997 Mar; 44(2-3):87-94. PubMed ID: 9088780 [TBL] [Abstract][Full Text] [Related]
8. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864 [TBL] [Abstract][Full Text] [Related]
13. Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study. Hildt E; Lieb K; Bagusat C; Franke AG Biomed Res Int; 2015; 2015():621075. PubMed ID: 26064931 [TBL] [Abstract][Full Text] [Related]
14. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960 [TBL] [Abstract][Full Text] [Related]
15. The costs of crime associated with stimulant use in a Canadian setting. Enns B; Krebs E; DeBeck K; Hayashi K; Milloy MJ; Richardson L; Wood E; Nosyk B Drug Alcohol Depend; 2017 Nov; 180():304-310. PubMed ID: 28942287 [TBL] [Abstract][Full Text] [Related]
16. Responding to global stimulant use: challenges and opportunities. Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R Lancet; 2019 Nov; 394(10209):1652-1667. PubMed ID: 31668409 [TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes of stimulant misusers: one year follow-up results from the national treatment outcome research study (NTORS). Gossop M; Marsden J; Stewart D Addict Behav; 2000; 25(4):509-22. PubMed ID: 10972443 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials. Kishi T; Matsuda Y; Iwata N; Correll CU J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105 [TBL] [Abstract][Full Text] [Related]